The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 02, 2010
Filed:
Feb. 10, 2004
Scott Eugene Conner, Indianapolis, IN (US);
Lynn Stacy Gossett, Indianapolis, IN (US);
Jonathan Edward Green, Avon, IN (US);
Winton Dennis Jones, Jr., Carmel, IN (US);
Nathan Bryan Mantlo, Brownsburg, IN (US);
Donald Paul Matthews, Indianapolis, IN (US);
Daniel Ray Mayhugh, Carmel, IN (US);
Daryl Lynn Smith, Fishers, IN (US);
Jennifer Ann Vance, San Jose, CA (US);
Xiaodong Wang, Carmel, IN (US);
Alan M Warshawsky, Carmel, IN (US);
Leonard Larry Winneroski, Jr., Greenwood, IN (US);
Yanping Xu, Fishers, IN (US);
Guoxin Zhu, Noblesville, IN (US);
Scott Eugene Conner, Indianapolis, IN (US);
Lynn Stacy Gossett, Indianapolis, IN (US);
Jonathan Edward Green, Avon, IN (US);
Winton Dennis Jones, Jr., Carmel, IN (US);
Nathan Bryan Mantlo, Brownsburg, IN (US);
Donald Paul Matthews, Indianapolis, IN (US);
Daniel Ray Mayhugh, Carmel, IN (US);
Daryl Lynn Smith, Fishers, IN (US);
Jennifer Ann Vance, San Jose, CA (US);
Xiaodong Wang, Carmel, IN (US);
Alan M Warshawsky, Carmel, IN (US);
Leonard Larry Winneroski, Jr., Greenwood, IN (US);
Yanping Xu, Fishers, IN (US);
Guoxin Zhu, Noblesville, IN (US);
Eli Lilly and Company, Indianapolis, IN (US);
Abstract
The present invention is directed to a compound of Formula (I): and pharmaceutically acceptable salts, solvates, hydrates or stereoisomers thereof, which are useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.